FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma
Syndicate content

generic drugs news from FierceHealthcare

News

New York to offer prescription drug discounts

New York is set to offer prescription drug discount cards for eligible residents. The New York Prescription Saver Cards, which will be available next week, are targeted at residents who are... Read more...

Healthcare spending growth slows; White House to target 'pay for delay' pharma deals;

> CMS is projecting that the growth in national healthcare spending will slow in 2009, but will nonetheless continue to grow faster than the economy given the current recession. Article > The... Read more...

Retail pharmacies' generic price war draws customers

Generics are generally a high-profit area, but lately retail pharmacies have been pretty aggressive in lowering their generic prices. Each pharmacy is trying to undercut their competitors and draw... Read more...

Generics save consumers, insurers $1 billion

Apparently, the worsening economy has an upside: it drove consumer demand for generic treatments up by 5.4 percent. That, combined with the large number of generics entering the market this year and... Read more...

Cigna lowers copay on cholesterol drug Lipitor

In recent times, we've been telling you that patients are not only avoiding elective procedures, but sometimes skipping prescribed medications to save money; apparently health insurer Cigna has been... Read more...

EU calls out drug companies on anti-competitive practices

The European Union has come out against several drug companies, saying that they were costing billions of dollars by delaying generics from making it to market. Some of the methods of delaying... Read more...

Insurers give doctors 'kickbacks' for prescribing generic drugs

We all know how the pharmaceutical industry tries to get doctors to prescribe brand-name drugs even though a generic is available, for their own profit. But what about the flip-side of that problem:... Read more...

Medicare overpaid for prescription drugs with generic versions

Medicare overpaid by millions for a cancer drug sold by Pfizer earlier this year because there was a delay in the agency updating its pricing formula, according to a new report from the HHS Office of... Read more...